Genespire

The promise of a cure

Milan, Italy · Founded 2020 · $69.4M raised

Headquarters
Milan
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$69.4M
Last Round
$52.0M Series BSep 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Genespire is a preclinical-stage biotechnology company based in Milan, Italy, focused on developing next-generation gene therapies using immune-shielded lentiviral vectors for children with severe genetic diseases. Founded as a spin-off from SR-Tiget (San Raffaele Telethon Institute for Gene Therapy) in March 2020, the company's lead program GENE202 targets methylmalonic acidaemia (MMA) and has received Orphan Drug Designation from both the FDA and the European Commission. Genespire's approach combines proprietary vector engineering with deep clinical expertise from its academic founders to create potentially curative, single-dose treatments for lysosomal storage and other rare inherited disorders.

Summary

Genespire is a Biotech company based in Milan, Italy, founded in 2020. It has raised $69.4M in total across 2 rounds, most recently a $52.0M Series B round in Sep 2024. Investors include Sofinnova Partners, XGEN Venture and CDP Venture Capital SGR.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2024
$52.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genespire on Indexed.vc
<a href="https://indexed.vc/companies/genespire"><img src="https://indexed.vc/api/badge/company/genespire" alt="Genespire on Indexed.vc" width="260" height="76" /></a>